Platelet-specific markers are associated with monocyte-platelet aggregate formation and thrombin generation potential in advanced atherosclerosis

被引:40
作者
Gremmel, Thomas [1 ]
Ay, Cihan [2 ]
Riedl, Julia [2 ]
Kopp, Christoph W. [1 ]
Eichelberger, Beate [3 ]
Koppensteiner, Renate [1 ]
Panzer, Simon [3 ]
机构
[1] Med Univ Vienna, Div Angiol, Dept Internal Med 2, Waehringer Guertel 18-20, A-1090 Vienna, Austria
[2] Med Univ Vienna, Clin Div Hematol & Hemostaseol, Dept Internal Med 1, A-1090 Vienna, Austria
[3] Med Univ Vienna, Dept Blood Grp Serol & Transfus Med, A-1090 Vienna, Austria
关键词
Platelet factor-4; thrombospondin-1; soluble CD40 ligand; soluble P-selectin; thrombin generation potential; SOLUBLE P-SELECTIN; VENOUS THROMBOEMBOLISM; CD40; LIGAND; VIENNA CANCER; RISK; ACTIVATION; COAGULATION; PREDICTION; INITIATION; DISEASE;
D O I
10.1160/TH15-07-0598
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Platelet activation and thrombin generation are crucial steps in primary and secondary haemostasis. However, both also play major roles in intravascular thrombus formation and therefore in the development of adverse cardiovascular events. In the current study, we first sought to investigate the associations of the platelet biomarkers platelet factor (PF)-4, thrombospondin (TSP)-1, soluble CD40 ligand (sCD40L), and soluble P-selectin (sP-selectin) with each other and with monocyte-platelet aggregate (MPA) formation in 316 patients undergoing angioplasty and stenting. To better understand the interplay between platelet activation and thrombin generation, we subsequently investigated the associations of the platelet biomarkers with thrombin generation potential. The mostly platelet-specific markers PF-4, TSP-1 and sCD40L correlated strongly with each other (all p < 0.001), and the best correlation was observed between PF-4 and TSP-1 (r = 0.91). In contrast, sP-selectin, which derives from platelets and endothelial cells, correlated rather poorly with TSP-1 (r = 0.12, p = 0.04), and did not correlate with PF-4 and sCD40L. While PF-4, TSP-1 and sP-selectin correlated significantly with in vivo MPA formation (all p < 0.001), no such association was found between sCD40L and MPA formation. PF-4, TSP-1 and sCD40L correlated strongly with peak thrombin generation (all p < 0.001) with the best correlation between PF-4 and peak thrombin generation (r = 0.55), whereas sP-selectin did not correlate with peak thrombin generation. Likewise, PF-4, TSP-1 and sCD40L correlated significantly with the area under the thrombin generation curve (AUC; all p < 0.01), whereas sP-selectin did not correlate with the AUC. In conclusion, platelet-specific markers are associated with MPA formation and thrombin generation potential in patients with advanced atherosclerosis.
引用
收藏
页码:615 / 621
页数:7
相关论文
共 35 条
  • [1] High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)
    Ay, Cihan
    Simanek, Ralph
    Vormittag, Rainer
    Dunkler, Daniela
    Alguel, Guelay
    Koder, Silvia
    Kornek, Gabriela
    Marosi, Christine
    Wagner, Oswald
    Zielinski, Christoph
    Pabinger, Ingrid
    [J]. BLOOD, 2008, 112 (07) : 2703 - 2708
  • [2] P-selectin gene haplotypes modulate soluble P-selectin concentrations and contribute to the risk of venous thromboembolism
    Ay, Cihan
    Jungbauer, Lea V.
    Kaider, Alexandra
    Koder, Silvia
    Panzer, Simon
    Pabinger, Ingrid
    Mannhalter, Christine
    [J]. THROMBOSIS AND HAEMOSTASIS, 2008, 99 (05) : 899 - 904
  • [3] High concentrations of soluble P-selectin are associated with risk of venous thromboembolism and the P-selectin Thr715 variant
    Ay, Cihan
    Jungbauer, Lea V.
    Sailer, Thomas
    Tengler, Theres
    Koder, Silvia
    Kaider, Alexandra
    Panzer, Simon
    Quehenberger, Peter
    Pabinger, Ingrid
    Mannhalter, Christine
    [J]. CLINICAL CHEMISTRY, 2007, 53 (07) : 1235 - 1243
  • [4] Prediction of Venous Thromboembolism in Patients With Cancer by Measuring Thrombin Generation: Results From the Vienna Cancer and Thrombosis Study
    Ay, Cihan
    Dunkler, Daniela
    Simanek, Ralph
    Thaler, Johannes
    Koder, Silvia
    Marosi, Christine
    Zielinski, Christoph
    Pabinger, Ingrid
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15) : 2099 - 2103
  • [5] Effects of clopidogrel on soluble CD40 ligand and on high-sensitivity C-reactive protein in patients with stable coronary artery disease -: art. no. e1
    Azar, RR
    Kassab, R
    Zoghbi, A
    Aboujaoudé, S
    El-Osta, H
    Ghorra, P
    Germanos, M
    Salamé, E
    [J]. AMERICAN HEART JOURNAL, 2006, 151 (02) : 521.e1 - 521.e4
  • [6] Blann AD, 1997, THROMB HAEMOSTASIS, V77, P1077
  • [7] Mechanisms of disease:: Platelet activation and atherothrombosis
    Davi, Giovanni
    Patrono, Carlo
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (24) : 2482 - 2494
  • [8] Soluble CD40 ligand:interleukin-10 ratio predicts in-hospital adverse events in patients with ST-segment elevation myocardial infarction
    Dominguez-Rodriguez, Alberto
    Abreu-Gonzalez, Pedro
    Garcia-Gonzalez, Martin J.
    Kaski, Juan Carlos
    [J]. THROMBOSIS RESEARCH, 2007, 121 (03) : 293 - 299
  • [9] Initiation of coagulation by tissue factor carriers in blood
    Engelmann, B
    [J]. BLOOD CELLS MOLECULES AND DISEASES, 2006, 36 (02) : 188 - 190
  • [10] Engelmann B, 2003, THROMB HAEMOSTASIS, V89, P3